Forteo 560 MCG/2.24 ML pen INJ 2.24ML

Ended Awarded Last action

Contract number
SPE2DR26F9Q2Q
Awardee
Awarding agency
Obligated
$49,833

Award facts

Contract value 100% obligated
$49,832.84 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency (DLA) awarded a $49,832.84 delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. The DLA Troop Support Medical IDC positions AmerisourceBergen to serve customers including the Defense Health Agency and U.S. Coast Guard, with this current delivery order for Forteo—a bone density medication used in osteoporosis treatment—exemplifying the specialized pharmaceutical commodities supplied through the prime vendor arrangement.

Quick answers

Who was awarded contract SPE2DR26F9Q2Q?

SPE2DR26F9Q2Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.

How much is contract SPE2DR26F9Q2Q worth?

The government has obligated $49,833 on SPE2DR26F9Q2Q.

Is contract SPE2DR26F9Q2Q an order under another contract?

Yes. SPE2DR26F9Q2Q is a delivery order under SPE2DR25D3020, an indefinite delivery contract.

Was contract SPE2DR26F9Q2Q competed?

The extent of competition for SPE2DR26F9Q2Q was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award